Description
We have identified novel molecules expressed during the early events of ovarian cancer invasion to healthy tissue. We hypothesize that these molecules are key to the metastatic process, and by specifically disrupting their expression we will disrupt the invasion process. This work will seeks to develop new therapeutic strategies to block ovarian cancer metastasis and the formation of metastatic nodules.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
Cancer, Ovarian Cancer, Metastasis
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options
Honours
BMedSc(Hons)
Time commitment
Full-time
Physical location
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors
Dr
Laura Moffitt
(External)